Thx but no thx . Theres a real risk that the FDA inspection of the Shilpa plant in India is being pushed back due to cut backs in available propane etc . Shilpa may have to prioritize maintaining existing FDA approved drug shipments . The Vivo director has more pressing things to deal with ...eg how to redeploy the $ from the SLNO sale when that goes thru .
I reduced my position by 1/3rd and will re add if we go below $6 or if UNCY comes out and confirms that the FDA inspection is on schedule and theres no change on a decision on approval by June 28th . I still think UNCY eventually gets bt out ...just as whats apparently happening with SLNO JMO IF UNCY comes out and confirms FDA inspection still on track ...no delays ...and I have to add back at higher prices ...so be it
Market Data 
Markets 
AI
